Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
Aliment Pharmacol Ther
.
2016 May;43(9):1021-2.
doi: 10.1111/apt.13574.
Authors
S Madonia
1
,
E Orlando
2
,
B Stagno
2
,
M Cannizzaro
2
,
G Madonia
2
,
M Cottone
2
Affiliations
1
Department of Medicine, V. Cervello Hosptital, Palermo, Italy. salvomadonia.sm@gmail.com.
2
Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
PMID:
27040170
DOI:
10.1111/apt.13574
No abstract available
Publication types
Letter
Comment
MeSH terms
Bilirubin*
Gilbert Disease*
Hepatitis C, Chronic / drug therapy
Humans
Liver Cirrhosis / drug therapy
Ribavirin / therapeutic use
Substances
Ribavirin
Bilirubin